Investing.com - Financial Markets Worldwide

Aker Biomarine AS (AKBM)

Oslo
Symbol
Exchange
Currency
AKBM·Oslo·NOK
AKBMNOK·Stockholm·NOK
Currency in NOK
81.80
-0.80(-0.97%)
Closed·

AKBM Financial Summary

Key Ratios

P/E Ratio-49.5
Price/Book4.33
Debt / Equity122.39%
Return on Equity-5.19%
Dividend Yield54.48%
EBITDA36.60M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa288.59262.1277.2196.3199
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa112.5688.1114.872.569.1
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa8.72-6.916.3-10.3-5.3
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-5.46-810-9180.3
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa700.43757.5822.4827.1387.4
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa70.9477.3104.7112.953.2
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa373.17370.4378.7366.5173.9
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa-38.45-49.05-34.7-24.4574.03
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-51.042.615.147.412.2
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-2.05-81.1-56.4-48.9379.4
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa50.1678.952.56.7-404
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-2.930.411.25.2-12.5
* In Millions of USD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.15%
Dividend Yield
54.48%
Industry Median 3.94%
Annualised payout
45.00
Paid unevenly
5-Years Growth
-
Growth Streak
Unlock

Analyst Ratings

0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 61.55
(-24.76% Downside)

Earnings

Latest Release
Jul 11, 2025
EPS / Forecast
-0.17 / -0.0007
Revenue / Forecast
55.15M / 55.15M
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Aker Biomarine AS's earnings for the latest quarter?

The Aker Biomarine AS EPS (TTM) is -0.15. Aker Biomarine AS reported sales of 55.30, net income of -14.50, and EPS of -0.17 for the latest quarter.

What was Aker Biomarine AS's net income for the latest quarter?

Aker Biomarine AS's net income for the latest quarter was -14.50.

How did Aker Biomarine AS's performance compare year-over-year in the latest quarter?

The company's revenue moved from 50.80 in the previous quarter to 55.30 in the latest quarter, and net income moved from -3.10 to -14.50 compared to the previous quarter.

What is Aker Biomarine AS's net profit margin on a TTM basis?

Aker Biomarine AS's trailing twelve months (TTM) net profit margin is 90.60%.

How does Aker Biomarine AS's debt to equity ratio compare to industry standards?

Aker Biomarine AS's total debt-to-equity ratio is 122.39%.

What is Aker Biomarine AS's return on investment on a TTM basis?

Aker Biomarine AS's trailing twelve months (TTM) return on investment (ROI) is -5.19%.

Did Aker Biomarine AS gain or lose cash last quarter?

In the latest quarter, Aker Biomarine AS's net change in cash was 3.40 million.

What were Aker Biomarine AS's total assets and liabilities in the latest quarter?

As of the latest quarter, Aker Biomarine AS reported total assets of 387.00 million and total liabilities of 74.10 million.

How has Aker Biomarine AS's total revenue grown this year?

Aker Biomarine AS's total revenue was 50.80 in the previous quarter and 55.30 in the latest quarter.

What is Aker Biomarine AS's gross margin on a TTM basis?

Aker Biomarine AS's trailing twelve months (TTM) gross margin is 37.13%.

What was Aker Biomarine AS's revenue per share for the latest quarter?

Aker Biomarine AS's revenue per share for the latest quarter was 69.12.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.